Head-to-head · Value Score
CoreAge Rx vs MedLeanRx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, MedLeanRx a 71. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameMedLeanRx
#226 · Grade C · Watch List
Est. first month
From $149/mo (starting dose, compounded)
Save ~89% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 71 — an est. $149/mo first month, with no teaser step-up baked in. MedLeanRx isn't out of it: Shoppers who want texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | MedLeanRx |
|---|---|---|
| Value Score | 93 (A+) | 71 (C) |
| Est. first month | $149/mo | From $149/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~89% |
| Semaglutide | $149/mo | From $149/mo (starting dose, compounded) |
| Tirzepatide | $349/mo | From $269/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 1 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
MedLeanRx
MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.
Why it's a deal
- Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
- Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
- Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
- LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
- Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips
The fine print
- Texas only — not available in the other 49 states
- Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
- Strict no-refund policy: 'All sales are final' per Terms & Conditions
- Pharmacy partner not publicly named — a transparency gap for a compounding service
- Legal entity name and founding details not published on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to MedLeanRx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.